The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,370.00
Bid: 12,370.00
Ask: 12,374.00
Change: 38.00 (0.31%)
Spread: 4.00 (0.032%)
Open: 12,350.00
High: 12,432.00
Low: 12,314.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Ocado Signs Deal In Japan; Reach Decline Slows

Fri, 29th Nov 2019 07:43

(Alliance News) - Stock prices in London are set to open lower on Friday, taking direction from a disappointing session in Asia as Hong Kong gears up for another weekend of unrest.

In early UK company news, Ocado has signed a partnership with Japanese grocer Aeon, the US FDA has granted AstraZeneca's Imfinzi priority review, and newspaper publisher Reach said its annual trading was in line with management expectations.

IG says futures indicate the FTSE 100 index of large-caps to open 30.83 points lower at 7,385.60 on Thursday. The UK flagship index closed down 13.35 points, or 0.2%, at 7,416.43 on Thursday.

Markets in Europe had stumbled into the red on Thursday amid fears US legislation supporting pro-democracy protesters in Hong Kong could derail trade talks with China.

China threatened retaliation against Washington on Thursday after US President Donald Trump signed legislation supporting Hong Kong pro-democracy protesters, just as the world's top two economies edge towards a trade truce.

"If anything, yesterday's declines were pretty modest given the circumstances, though one should also take into account the absence of US markets, as well as fairly low volumes. Nonetheless if investors were really concerned about a significant escalation in tensions, yesterday's price action certainly didn't show it," said CMC Markets Chief Market Analyst Michael Hewson.

He continued: "Asia markets this morning have seen more of a decline and this is likely to see a similarly weak European open this morning though some of the losses could also be some month end portfolio readjustment, after a fairly decent November."

"It's still expected to be a fairly quiet end to the week and month today with markets in Europe set to finish November in positive territory, and a third successive monthly gain."

Adding to the tensions, Hong Kong police ended their two-week siege of a university campus that became a battleground with pro-democracy protesters, as activists vowed to hold fresh rallies and strikes in the coming days.

Renewed calls to hit the streets came after Beijing and city leader Carrie Lam refused further political concessions despite a landslide victory for pro-democracy parties in local elections last weekend.

In Asia on Friday, the Japanese Nikkei 225 index closed down 0.5%. In China, the Shanghai Composite closed down 0.6%, while the Hang Seng index in Hong Kong is 2.1% lower.

Financial markets in the US were closed on Thursday for the Thanksgiving holiday and will reopen on Friday for a half-day session.

Commenting on the session in Asia, AxiTrader's Stephen Innes said: "So much for the thought that 'risk-on' is trying to emerge from its 24 hours Hong Kong bill-imposed cocoon as the markets remain very much in a defensive mode ahead of the weekend. There are far too many combinations of headline risk to navigate, which for today's session, is bringing about a bit of randomness amid sparse liquidity as traders appear to be flattening out long risk positions.

"Traders are probably getting a tad jittery about turning the page on November without a trade talk venue as December 15 and the possible imposition of 15% tariffs on USD160 billion of Chinese goods looms ominously.

Turning to the London Stock Exchange, Ocado said its Smart Platform will now be used in Japan by Aeon. The Japanese company has 21,000 food stores across 14 countries but will be opening a new online business, with help from Ocado.

The agreement will see the development of a national fulfilment network to serve the whole of the Japanese market, with expected sales capacity of around JPY600 billion by 2030, growing to approximately JPY1 trillion by 2035. The service is expected to go live in 2023.

Aeon will pay Ocado upfront fees upon signing and during the development phase, then ongoing fees linked to both sales achieved and installed capacity within each customer fulfilment centres and service criteria.

Pharma giant AstraZeneca received good news. The US Food & Drug Administration has granted the company's Imfinzi small cell lung cancer treatment a priority review.

The FDA has accepted a supplemental biologics licence application for the drug, based on positive results from phase III of the Caspian trial - which showed Imfinzi, in combination with standard-of-care chemotherapy, demonstrated a "statistically significant and clinically meaningful improvement in overall survival versus standard of care".

Reach said its trading in in the past five months has been in line with management views.

Like-for-like sales were down 4.4% in the period to November 24, but this is improved upon the 6.6% decline seen in the same period the year prior.

Like-for-like print revenue in the five month period was down 7.3%, compared to down 8.2% a year before, but digital grew by 14%, versus 9.3% a year prior.

Reach said it is confident its 2019 performance will meet expectations.

Student accommodation provider Unite Group has completed the acquisition of Liberty Living Group, a wholly owned subsidiary of the Canada Pension Plan Investment Board. Unite has issued 72.6 million shares at 25 pence each to Liberty Living to complete the deal. Unite will have 363.5 million shares in issue following the deal.

Investec updated the market on its planned demerger and planned listing of its asset management business, which is to be renamed Ninety One Ltd.

Ninety One will be dual listed, in London and Johannesburg, and is expected to be complete in March 2020.

Transferring Investec Asset Management's assets into Ninety One is expected to have a positive impact on Investec's resulting CET1 ratio, of about 1.3% to 12.0%.

The banking group is expecting to incur a GBP56 million cost for the demerger but Investec "strongly" believes the move will simplify its business and improve its long term prospects. Investec has committed to RoE between 12% and 16% for its Bank & Wealth business through 2022.

Estate agent Countrywide has sold commercial real estate consultancy firm Lambert Smith Hampton for GBP38 million in cash. Countrywide said the business was non-core, and the funds will be used for its business turnaround. It also has agreed an amended credit facility with its lenders.

Countrywide additionally announced on a share consolidation, but this first requires shareholder approval at its upcoming annual general meeting.

Countrywide is proposing a 50 for 1 consolidation. The company currently has 1.64 billion shares in issue. Countrywide said the consolidation will improve its market liquidity, and reduce volatility and spread.

"The group continues to make operational progress in its turnaround and confirms that it remains on course to deliver a full year result in line with the board's expectations," Countrywide added.

In currencies, sterling was quoted at USD1.2913 early Friday, down from USD1.2951 at the London equities close on Thursday.

The euro was quoted at USD1.1010 early Friday, up on USD1.1002 late Thursday. Against the yen, the dollar was quoted at JPY109.50, flat versus JPY109.50.

Back in the UK, a row has erupted between the Conservative Party and Channel 4, with the Tories saying the broadcaster "conspired" with Jeremy Corbyn to block them from a TV leaders' debate.

The party has made a formal complaint to Ofcom's election committee as an ice sculpture was used in Boris Johnson's place in the Channel 4 News debate on climate change.

The UK prime minister was again accused of "running scared" when he did not join the other party leaders, with Michael Gove instead turning up and asking if he could stand in for Johnson, before being turned away because he is not a party leader.

In commodities, gold was quoted at USD1,457.50 early Friday, higher on USD1,455.02 at the London equities close on Thursday.

Brent oil was quoted at USD63.12 early Friday, higher compared to USD62.72 at the London equities close on Thursday.

The economic events calendar on Friday has Germany unemployment data at 0855 GMT, UK mortgage approvals at 0930 GMT and eurozone inflation and jobless figures at 1000 GMT.

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.